M Hecht Selected Research

Bortezomib (Velcade)

9/2007

Bortezomib inhibits human osteoclastogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Hecht Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 01/2005
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2022
1	COVID-19 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Oropharyngeal Neoplasms 01/2020
1	Radiodermatitis 06/2015
1	Melanoma (Melanoma, Malignant) 06/2015
1	Chromosome Breakage 06/2015
1	Skin Neoplasms (Skin Cancer) 06/2015
1	Brain Diseases (Brain Disorder) 04/2014
1	Glioblastoma (Glioblastoma Multiforme) 04/2014
1	Jaundice (Icterus) 04/2014
1	Chemical and Drug Induced Liver Injury 04/2014
1	Muscle Spasticity (Spastic) 04/2011
1	Exsanguination 11/2008
1	Multiple Myeloma 09/2007
1	Bone Resorption 09/2007
1	Allergic Contact Dermatitis 07/2005
1	Skin Diseases (Skin Disease) 07/2005
1	Atopic Dermatitis (Atopic Eczema) 07/2005
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2005
1	Disease Progression 05/2005
1	Paralysis (Palsy) 05/2005
1	Hepatocellular Carcinoma (Hepatoma) 08/2004
1	Respiratory Hypersensitivity 09/2003
1	Asthma (Bronchial Asthma) 09/2003
1	Inflammation (Inflammations) 09/2003
1	Polyneuropathies (Polyneuropathy) 05/2003
1	Trismus (Lockjaw) 02/2002
1	Respiratory Sounds (Crackle) 02/2002

Drug/Important Bio-Agent (IBA)

2	Botulinum Toxins (Botulinum Toxin)IBA 04/2011 - 02/2002
1	VemurafenibIBA 06/2015
1	dabrafenibIBA 06/2015
1	Temozolomide (Temodar)FDA LinkGeneric 04/2014
1	Alkylating AgentsIBA 04/2014
1	Transaminases (Aminotransferases)IBA 04/2014
1	Pharmaceutical PreparationsIBA 04/2014
1	EnzymesIBA 04/2014
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 09/2007
1	LigandsIBA 09/2007
1	NF-kappa B (NF-kB)IBA 09/2007
1	Bortezomib (Velcade)FDA Link 09/2007
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2007
1	PS1145IBA 09/2007
1	CilomilastIBA 07/2005
1	Sirolimus (Rapamycin)FDA Link 07/2005
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2005
1	AntioxidantsIBA 05/2005
1	Superoxide DismutaseIBA 05/2005
1	Vitamin E FDA LinkGeneric 05/2005
1	Riluzole FDA LinkGeneric 05/2005
1	alpha-Tocopherol FDA Link 05/2005
1	Indicators and Reagents (Reagents)IBA 01/2005
1	Transcription Factors (Transcription Factor)IBA 08/2004
1	Nerve Growth Factor (NGF)IBA 09/2003
1	AllergensIBA 09/2003

Therapy/Procedure

6	Therapeutics 01/2022 - 05/2003
1	Immunotherapy 07/2022
1	Radiotherapy 06/2015
1	Adjuvant Chemotherapy 04/2014
1	Chemoradiotherapy 04/2014
1	Injections 04/2011
1	Lasers (Laser) 11/2008